Depression symptoms increase the risk for initiation or switching to biologic therapy in pediatric inflammatory bowel disease patients in remission

被引：0
|
作者：
F. Milo
G. Angelino
E.F. Romeo
P. De Angelis
P. Tabarini
机构：
[1] Bambino Gesù Children’s Hospital,Psychology Unit
[2] IRCCS,Gastroenterology and Nutrition Unit
[3] Bambino Gesù Children’s Hospital,undefined
[4] IRCCS,undefined
来源：
BMC Gastroenterology | / 23卷
关键词：
Pediatric; Inflammatory bowel disease; Depression; Anxiety; Biologic therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Dual Biologic and Small Molecule Therapy for the Treatment of Refractory Pediatric Inflammatory Bowel Disease
    Dolinger, Michael T.
    Spencer, Elizabeth A.
    Lai, Joanne
    Dunkin, David
    Dubinsky, Marla C.
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (08) : 1210 - 1214
  • [42] IMPACT OF BIOLOGIC THERAPY ON RESOLUTION OF FATIGUE SYMPTOMS IN PATIENTS WITH ACTIVE INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY
    Borren, Nienke Z.
    Tan, William
    Andrews, Elizabeth
    Van der Woude, Christien Janneke
    Colizzo, Francis
    Luther, Jay
    Khalili, Hamed
    Garber, John J.
    Ananthakrishnan, Ashwin
    GASTROENTEROLOGY, 2019, 156 (06) : S431 - S432
  • [43] Depression Subtypes in Pediatric Inflammatory Bowel Disease
    Szigethy, Eva M.
    Youk, Ada O.
    Benhayon, David
    Fairclough, Diane L.
    Newara, Melissa C.
    Kirshner, Margaret A.
    Bujoreanu, Simona I.
    Mrakotsky, Christine
    Bousvaros, Athos
    Srinath, Arvind I.
    Keljo, David J.
    Kupfer, David J.
    DeMaso, David R.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2014, 58 (05): : 574 - 581
  • [44] Morning administration of biologic therapy is associated with decreased risk of treatment failure in patients with Inflammatory Bowel Disease
    Odeyemi, I
    Baum, K.
    Colombel, J. F.
    Hirten, R. P.
    Ungaro, R. C.
    Renard, B. Y.
    Ibing, S.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1540 - I1541
  • [45] PREDICTORS OF PERSISTENT FATIGUE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN BIOLOGIC-INDUCED CLINICAL REMISSION
    Borren, Nynke
    Van der Woude, Christien Janneke
    Ananthakrishnan, Ashwin
    GASTROENTEROLOGY, 2018, 154 (06) : S807 - S807
  • [46] Inflammatory bowel disease and depressive symptoms: the prevalence and factors associated with depression in patients with inflammatory bowel disease on intravenous biological therapy - single center experience
    Smolovic, B.
    Lukic, M.
    Bojovic, S.
    Vukovic, M. N.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (11) : 4008 - 4016
  • [47] Inflammatory bowel disease surgery in the biologic therapy era
    Strong, Scott A.
    CURRENT OPINION IN GASTROENTEROLOGY, 2012, 28 (04) : 349 - 353
  • [48] The Role of Dual Biologic Therapy in Inflammatory Bowel Disease
    Molly, Stone
    Margaret, Morrison
    Erin, Forster
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S20 - S20
  • [49] Biologic therapy for inflammatory bowel disease comes of age
    Hanauer S.B.
    Current Gastroenterology Reports, 2007, 9 (6) : 485 - 488
  • [50] RISK STRATIFICATION TO INCREASE VENOUS THROMBOEMBOLISM PROPHYLAXIS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
    Levine, Anne E.
    Chi, Lisa Y.
    Sobczyk, Patricia
    Bousvaros, Athos
    Trenor, Cameron C.
    Zitomersky, Naamah
    INFLAMMATORY BOWEL DISEASES, 2019, 25 : S35 - S35
12345